Medicare Enrolled
Dr. Amy Wiegandt, MD
Internal Medicine · Wareham, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wiegandt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wiegandt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wiegandt
Dr. Amy Wiegandt is an internal medicine specialist in Wareham, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wiegandt performed 6,075 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Wiegandt received a total of $1,718 from 23 pharmaceutical and/or device companies across 97 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wiegandt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 2% volume in MA
$1,718 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,075
Medicare services
Top 2% in MA for internal medicine
Not available
Unique patients (not deduplicated)
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,860 | $18 | $32 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
787 | $97 | $315 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
532 | $63 | $217 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
251 | $3 | $17 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
241 | $49 | $82 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
241 | $134 | $299 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
216 | $31 | $72 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
210 | $72 | $138 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
201 | $11 | $79 |
| Adm sarscv2 bvl 50mcg/.5ml a | 152 | $42 | $66 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
136 | $4 | $11 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
126 | $4 | $18 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
102 | $17 | $65 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
95 | $64 | $171 |
| Respiratory virus test for SARS-CoV-2, influenza A/B, and RSV A laboratory test that detects the presence of SARS-CoV-2 (COVID-19), influenza A, influenza B, and respiratory syncytial virus (RSV) in an upper respiratory specimen. |
94 | $138 | $293 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
86 | $5 | $5 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
76 | $95 | $200 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
71 | $42 | $61 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
71 | $145 | $420 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
68 | $50 | $109 |
| COVID-19 vaccine (Moderna bivalent) An intramuscular injection of the SARS-CoV-2 vaccine containing 50 micrograms in a 0.5 mL dose. |
63 | $143 | $206 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
51 | $59 | $135 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $43 | $130 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
40 | $41 | $104 |
| Urine microalbumin test A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function. |
34 | $6 | $17 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
31 | $12 | $65 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
29 | $228 | $377 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
25 | $34 | $107 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
20 | $166 | $326 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
19 | $81 | $264 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
19 | $39 | $75 |
| Sarscov2 vac 25 mcg/.25ml im | 18 | $143 | $175 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
16 | $67 | $130 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
15 | $14 | $66 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
15 | $19 | $38 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
12 | $22 | $44 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
12 | $76 | $103 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$1,718
Total received (2018-2024)
Avg $245/year across 7 years
Top 26% in MA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
97
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$238
2023
$281
2022
$213
2021
$101
2020
$98
2019
$188
2018
$599
Payments by company (2024)
Amgen Inc.
$136
Novo Nordisk Inc
$35
Mylan Specialty L.P.
$31
Merck Sharp & Dohme LLC
$20
Exact Sciences Corporation
$15
Top 3 companies account for 85.0% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$279
GlaxoSmithKline, LLC.
$271
Novo Nordisk Inc
$161
Amgen Inc.
$156
Boehringer Ingelheim Pharmaceuticals, Inc.
$121
AstraZeneca Pharmaceuticals LP
$107
AbbVie Inc.
$99
Janssen Pharmaceuticals, Inc
$76
ABBVIE INC.
$73
Mylan Specialty L.P.
$47
Astellas Pharma US Inc
$46
Abbott Laboratories
$41
Merck Sharp & Dohme LLC
$40
Sanofi Pasteur Inc.
$33
IDORSIA PHARMACEUTICALS US INC
$28
Hologic Sales and Service, LLC
$25
Myriad Women's Health, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$20
Dexcom, Inc.
$17
Exact Sciences Corporation
$15
Kowa Pharmaceuticals America, Inc.
$14
Merck Sharp & Dohme Corporation
$14
Novartis Pharmaceuticals Corporation
$13
Top 3 companies account for 41.4% of all-time payments
Associated products mentioned in payments ›
ANORO · ANORO ELLIPTA · APTIMA · BEVESPI AEROSPHERE · CHANTIX · Cologuard Collection Kit · Dexcom CGM · Dymista · ELIQUIS · ENTRESTO · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · GARDASIL · GARDASIL 9 · LYRICA · Livalo · MYRBETRIQ · MYRISK · Ozempic · PNEUMOVAX 23 · PRADAXA · PREMARIN · Prolia · QULIPTA · QUVIVIQ · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TOVIAZ · TRELEGY ELLIPTA · Tresiba · UBRELVY · VRAYLAR · Victoza · XARELTO · YUPELRI
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
381
County median income
$109,698
Nearest hospital to ZIP centroid (approximate)
CAPE COD & ISLANDS COMMUNITY MENTAL HEALTH CENTER
6.0 mi
6.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wiegandt is a clinical cardiology specialist, with above-average Medicare volume (top 2% in MA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wiegandt experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Wiegandt performed 1,860 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Wiegandt receive payments from pharmaceutical companies?
Yes. Dr. Wiegandt received a total of $1,718 from 23 companies across 97 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wiegandt's costs compare to other internal medicine physicians in Wareham?
Dr. Wiegandt's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wiegandt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Wareham
Browse internal medicine physicians in Wareham ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in MA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in MA
Which MA internal medicine physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology